Dr Peter Skarsgard, Vesalius President and Chief Medical Officer, will be presenting Vesalius TMVr solution twice during the EuroPCR 2024 event held in Paris from May 13th to 17th, 2024.
The first presentation will take place during the PCR Innovators Day on May 13th at 12:50 during the session titled: Transcatheter devices for mitral and tricuspid regurgitation: novel devices to address an unmet clinical need?
Then, on May 16th during the EuroPCR course programme, Dr Skarsgard will present Vesalius TMVr solution during the Innovation Session titled Valvular and structural interventions and held at 16:30.
EuroPCR is the world-leading event in interventional cardiovascular medicine. The Innovators Day features every year a handful of innovative startups with exceptional concepts and techniques.
For more details regarding this event, please click here.
Recent Comments